Prognostic factors for functional outcome of patients with optic nerve sheath meningiomas treated with stereotactic radiotherapy
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Erschienen in
-
In: Cancers, 13, 3, Article 522, S. 522-1-522-8
- Ereignis
-
Veröffentlichung
- (wo)
-
Bochum
- (wer)
-
Ruhr-Universität Bochum
- (wann)
-
2021
- Urheber
-
Pintea, Bogdan
Boström, Azize
Katsigiannis, Sotiris
Gousias, Konstantinos
Pintea, Rares
Baumert, Brigitta
Boström, Jan
- URN
-
urn:nbn:de:hbz:294-80152
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
25.04.2025, 14:15 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Pintea, Bogdan
- Boström, Azize
- Katsigiannis, Sotiris
- Gousias, Konstantinos
- Pintea, Rares
- Baumert, Brigitta
- Boström, Jan
- Ruhr-Universität Bochum
Entstanden
- 2021
Ähnliche Objekte (12)
Transient Enlargement in Meningiomas Treated with Stereotactic Radiotherapy
Transient Enlargement in Meningiomas Treated with Stereotactic Radiotherapy
Predicting survival in melanoma patients treated with concurrent targeted- or immunotherapy and stereotactic radiotherapy : : Melanoma brain metastases prognostic score
Prognostic implications of HIF-1α expression in anal squamous cell carcinoma treated with intensity-modulated radiotherapy (IMRT)
The pre-treatment c-reactive protein represents a prognostic factor in patients with oral and oropharyngeal cancer treated with radiotherapy
Efficacy of stereotactic body radiotherapy in patients with hepatocellular carcinoma not suitable for transarterial chemoembolization (HERACLES: HEpatocellular Carcinoma Stereotactic RAdiotherapy CLinical Efficacy Study)
Stereotactic radiotherapy combined with immunotherapy or targeted therapy for metastatic renal cell carcinoma
Multicenter analysis of stereotactic radiotherapy of the resection cavity in patients with brain metastases
Stereotactic body radiotherapy (SBRT) for medically inoperable lung metastases: a pooled analysis of the German working group "stereotactic radiotherapy"
Quality requirements for MRI simulation in cranial stereotactic radiotherapy: a guideline from the German Taskforce "Imaging in Stereotactic Radiotherapy"
Radiomics-based prediction of local control in patients with brain metastases following postoperative stereotactic radiotherapy
Stereotactic body radiotherapy (SBRT) for pulmonary metastases from renal cell carcinoma: a multicenter analysis of the German working group “Stereotactic Radiotherapy”
Transient Enlargement in Meningiomas Treated with Stereotactic Radiotherapy
Transient Enlargement in Meningiomas Treated with Stereotactic Radiotherapy
Predicting survival in melanoma patients treated with concurrent targeted- or immunotherapy and stereotactic radiotherapy : : Melanoma brain metastases prognostic score
Prognostic implications of HIF-1α expression in anal squamous cell carcinoma treated with intensity-modulated radiotherapy (IMRT)
The pre-treatment c-reactive protein represents a prognostic factor in patients with oral and oropharyngeal cancer treated with radiotherapy
Efficacy of stereotactic body radiotherapy in patients with hepatocellular carcinoma not suitable for transarterial chemoembolization (HERACLES: HEpatocellular Carcinoma Stereotactic RAdiotherapy CLinical Efficacy Study)
Stereotactic radiotherapy combined with immunotherapy or targeted therapy for metastatic renal cell carcinoma
Multicenter analysis of stereotactic radiotherapy of the resection cavity in patients with brain metastases
Stereotactic body radiotherapy (SBRT) for medically inoperable lung metastases: a pooled analysis of the German working group "stereotactic radiotherapy"
Quality requirements for MRI simulation in cranial stereotactic radiotherapy: a guideline from the German Taskforce "Imaging in Stereotactic Radiotherapy"
Radiomics-based prediction of local control in patients with brain metastases following postoperative stereotactic radiotherapy
Stereotactic body radiotherapy (SBRT) for pulmonary metastases from renal cell carcinoma: a multicenter analysis of the German working group “Stereotactic Radiotherapy”
Transient Enlargement in Meningiomas Treated with Stereotactic Radiotherapy
Transient Enlargement in Meningiomas Treated with Stereotactic Radiotherapy
Predicting survival in melanoma patients treated with concurrent targeted- or immunotherapy and stereotactic radiotherapy : : Melanoma brain metastases prognostic score
Prognostic implications of HIF-1α expression in anal squamous cell carcinoma treated with intensity-modulated radiotherapy (IMRT)
The pre-treatment c-reactive protein represents a prognostic factor in patients with oral and oropharyngeal cancer treated with radiotherapy
Efficacy of stereotactic body radiotherapy in patients with hepatocellular carcinoma not suitable for transarterial chemoembolization (HERACLES: HEpatocellular Carcinoma Stereotactic RAdiotherapy CLinical Efficacy Study)
Stereotactic radiotherapy combined with immunotherapy or targeted therapy for metastatic renal cell carcinoma
Multicenter analysis of stereotactic radiotherapy of the resection cavity in patients with brain metastases
Stereotactic body radiotherapy (SBRT) for medically inoperable lung metastases: a pooled analysis of the German working group "stereotactic radiotherapy"
Quality requirements for MRI simulation in cranial stereotactic radiotherapy: a guideline from the German Taskforce "Imaging in Stereotactic Radiotherapy"
Radiomics-based prediction of local control in patients with brain metastases following postoperative stereotactic radiotherapy